Study to Evaluate the Safety and Efficacy of Batoclimab in Participants With Graves' Disease (GD)
Status:
Recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of 24 weeks of treatment with
batoclimab in adult participants with biochemically documented hyperthyroidism due to GD who
have failed to achieve euthyroidism with antithyroid drugs (ATDs).